2024 annual financial data
Immix Biopharma 2024 Net income growth
Direct answer
Net income growth was -40.11%.
Operating income was -22,674,680 USD and net income was -21,613,376 USD.
Operating cash flow was -14,595,102 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,674,680 USD
- Net income
- -21,613,376 USD
- Operating cash flow
- -14,595,102 USD